NanoString Technologies Inc is a biotechnology company involved in translational research and molecular diagnostics. The product portfolio is based on a novel digital molecular barcoding technology. This technology, nCounter Analysis System, uses molecular "barcodes" and single-molecule imaging to distinguish and count hundreds of unique transcripts in a single reaction. This system is used for performing cancer research, biomarker validation and screening, and next-generation sequencing validation.